Cassaday & Co Wealth Management LLC grew its stake in shares of Danaher Co. (NYSE:DHR – Free Report) by 2.3% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 4,661 shares of the conglomerate’s stock after acquiring an additional 107 shares during the quarter. Cassaday & Co Wealth Management LLC’s holdings in Danaher were worth $1,070,000 as of its most recent SEC filing.
A number of other institutional investors have also recently modified their holdings of DHR. AMF Tjanstepension AB acquired a new position in Danaher in the 3rd quarter worth about $5,923,000. Howard Capital Management Group LLC raised its stake in shares of Danaher by 4.1% in the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock worth $342,000 after purchasing an additional 48 shares during the last quarter. Foundations Investment Advisors LLC increased its position in shares of Danaher by 5.3% during the third quarter. Foundations Investment Advisors LLC now owns 1,637 shares of the conglomerate’s stock valued at $455,000 after acquiring an additional 82 shares during the last quarter. Private Advisor Group LLC increased its position in shares of Danaher by 5.6% during the third quarter. Private Advisor Group LLC now owns 45,631 shares of the conglomerate’s stock valued at $12,686,000 after acquiring an additional 2,431 shares during the last quarter. Finally, International Assets Investment Management LLC increased its position in Danaher by 40,196.5% in the third quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate’s stock worth $119,539,000 after buying an additional 428,897 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
Several equities research analysts recently issued reports on DHR shares. Guggenheim started coverage on Danaher in a research note on Thursday, December 19th. They set a “buy” rating and a $275.00 price objective for the company. Barclays decreased their price objective on Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a report on Thursday, January 30th. Bank of America upgraded Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price target on the stock in a report on Friday, December 13th. JPMorgan Chase & Co. dropped their price target on Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Finally, Citigroup decreased their target price on shares of Danaher from $285.00 to $265.00 and set a “buy” rating for the company in a research note on Thursday, January 30th. Seven investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $278.00.
Insider Buying and Selling
In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 11.10% of the stock is currently owned by corporate insiders.
Danaher Stock Up 1.5 %
NYSE:DHR opened at $208.10 on Friday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The stock has a 50-day simple moving average of $227.21 and a 200 day simple moving average of $247.52. The company has a market cap of $150.31 billion, a PE ratio of 39.41, a PEG ratio of 2.61 and a beta of 0.83. Danaher Co. has a 52-week low of $196.80 and a 52-week high of $281.70.
Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the business earned $2.09 earnings per share. On average, sell-side analysts expect that Danaher Co. will post 7.67 EPS for the current fiscal year.
Danaher Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a $0.32 dividend. This is a positive change from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a dividend yield of 0.62%. Danaher’s dividend payout ratio (DPR) is presently 20.45%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More
- Five stocks we like better than Danaher
- Earnings Per Share Calculator: How to Calculate EPS
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- What is the Hang Seng index?
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- What is a support level?
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.